Mcintyre Freedman & Flynn Investment Advisers Inc Haleon PLC Transaction History

Mcintyre Freedman & Flynn Investment Advisers Inc

$140 Billion
Q3 2024

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q1 2023 May 10, 2023	SELL	$7.57 - $8.37 $37,850 - $41,849	-5,000 Reduced 8.27%	55,440 $451 Million
Q4 2022 Feb 14, 2023	BUY	$5.96 - $8.06 $360,222 - $487,146	60,440 New	60,440 $484 Million

Others Institutions Holding HLN

# of Institutions

639

Shares Held

412M

Call Options Held

149K

Put Options Held

16K

Dodge & Cox San Francisco, CA

179M
Shares

$1.74 Billion
1.15% of portfolio
Clearbridge Investments, LLC New York, NY

37.4M
Shares

$362 Million
0.32% of portfolio
Harding Loevner LP Bridgewater, NJ

24.9M
Shares

$241 Million
1.54% of portfolio
Ken Fisher Fisher Asset Management, LLC | Camas, Wa

13.7M
Shares

$133 Million
0.06% of portfolio
Wellington Management Group LLP Boston, MA

9.15M
Shares

$88.8 Million
0.02% of portfolio

View Full List

About Haleon plc

Ticker HLN
Exchange
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 4,617,290,240
Market Cap $44.8B
Description
Haleon plc engages in the research and development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides therapeutic oral health, pain relief, respiratory health, digestive health, and other products, as well as vitamins, mineral...

More about HLN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Mcintyre Freedman & Flynn Investment Advisers Inc, based on Form 13F filings with the SEC.

News

Stay updated on Mcintyre Freedman & Flynn Investment Advisers Inc with notifications on news.

Account